Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-041610
Filing Date
2017-06-23
Accepted
2017-06-23 14:18:59
Documents
1
Period of Report
2017-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4822
  Complete submission text file 0001209191-17-041610.txt   6207
Mailing Address 735 BROAD ST STE 1105 CHATTANOOGA TN 37402
Business Address
MCKENZIE W THORPE (Reporting) CIK: 0001211462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37347 | Film No.: 17927204

Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations